Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 449 followers
Latest posts
Last updated about 11 hours ago
Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation: 06/03/2009, Revision: 23, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation...
ICH E14/S7B (R1) Q&As: The clinical evaluation of QT/ QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs - Questions and Answers
about 12 hours ago
ICH E14/S7B (R1) Q&As: The clinical evaluation of QT/ QTc interval prolongation...
Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation: 05/09/2013, Revision: 19, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation...
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 10, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 17, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 19, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation...
Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Date of authorisation: 18/11/2025, Revision: 1, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Brinsupri, Brensocatib, Date of authorisation...
List of eligible industry stakeholder organisations
about 17 hours ago
List of eligible industry stakeholder organisations
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 5, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 8, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of...
Nominations to the Network Portfolio Advisory Group
1 day ago
Nominations to the Network Portfolio Advisory Group